ISSN: 2332-0877

Jornal de doenças infecciosas e terapia

Acesso livre

Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.

Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores

Abstrato

Clostridium difficile Infection Rates Reduced at a Health Care System after Restriction of Respiratory Fluoroquinolones

Athena LV Hobbs and Katherine M Shea

Fluoroquinolones are one of the most commonly prescribed antibiotic classes in the United States and up to 81% of inpatient utilization has been deemed inappropriate. Our study, recently published in Antimicrobial Agents of Chemotherapy, aimed to determine the impact of respiratory fluoroquinolone education and restriction on utilization, appropriateness of quinolone-based therapy, and CDI rates within a health care system. Both phases of implementation were successful at significantly reducing respiratory fluoroquinolone utilization as well as CDI rates. Utilization was reduced by 48% after clinician education and 88% following implementation of restriction criteria. Mean monthly CDI cases also decreased by approximately 50% from pre-intervention to post-restriction.